EPD Solutions, A Philips Company
8
0
0
2
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 90/100
62.5%
5 terminated/withdrawn out of 8 trials
28.6%
-57.9% vs industry average
0%
0 trials in Phase 3/4
50%
1 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (8)
Patient Specific Optimized Therapy Post-Market Clinical Follow-up Study
Role: lead
Patient Specific Optimized Therapy (PSOT)
Role: lead
Prospective Procedural Data Collection for Continuous Improvement of the KODEX - EPD™ System Performance.
Role: lead
CLAIM: Using the KODEX-EPD System to Guide PaCing Lead Placements, A First In Man Study.
Role: lead
Evaluating the Performance of the KODEX-EPD CRyOballoon Occlusion Feature in Patients With Atrial Fibrillation
Role: lead
Dielectric Tissue Imaging in Cavotricuspid Isthmus Ablation
Role: lead
DURABLE-I Study: Dielectric Unravelling of Radiofrequency ABLation Effectiveness
Role: lead
Evaluation of the Safety, Feasibility and Usability of the EPD D700 System in Atrial Flutter Ablation Procedures
Role: lead
All 8 trials loaded